| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 122524 | GW2580 | 870483-87-7 | 98% | ![]() |
| GW2580 is an orally bioavailable inhibitor of c-FMS kinase; completely inhibited huma | ||||
| 122805 | Balipodect ( TAK-063 ) | 1238697-26-1 | 98% | ![]() |
| Balipodect (TAK 063 )is a novel PDE10A inhibitor. It has shown high inhibitory activi | ||||
| 122919 | Tenapanor | 1234423-95-0 | 98% | ![]() |
| Tenapanoris an inhibitor of the sodium-proton exchanger NHE3. Thisantiporter protein | ||||
| 122941 | Pacritinib(SB1518) | 937272-79-2 | ≧98.0% | ![]() |
| Pacritinib (SB1518) 是一种高选择性激酶抑制剂,对 JAK2、FLT3、IRAK1 和 | ||||
| 51627 | MK7622 | 1227923-29-6 | 98% by HPLC | ![]() |
| MK-7622isused as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for t | ||||
| 20267 | Almonertinib | 1899921-05-1 | 98% Min. | ![]() |
| Almonertinib is an orally available inhibitor of the epidermal growth factor receptor | ||||
| 10403 | CAY 10566 | 944808-88-2 | ≧98.0% | ![]() |
| CAY 10566是一种强效的选择性SCD-1抑制剂。 | ||||
| 25152 | Avutometinib ( 别名: Ro 5126766; CH5126766 ) | 946128-88-7 | ≧98.0% | ![]() |
| Avutometinib(别名:RO-5126766、CH-5126766)是一种正在开发的 Ras-Raf-ME | ||||
| 011813 | Avoralstat | 918407-35-9 | 95.0% | ![]() |
| Avoralstat(前身为BCX4161)是一种有效的小分子口服血浆激肽释放酶 | ||||
| 1662118 | MK-8931 ( Verubecestat ) | 1286770-55-5 | 98% by HPLC/HNMR | ![]() |
| MK-8931(verubecestat)是一种BACE抑制剂,是由默沙东公司研制开发。主 | ||||
| 611902 | PF-04979064 | 1220699-06-8 | ≧98.0% | ![]() |
| PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
| 6111110 | Nastorazepide | 209219-38-5 | 98% | ![]() |
| Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||
